Robert Blaustein - 21 Jan 2025 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EWTX	Restricted Stock Units	Award	$0	+30,000		$0.000000	30,000	21 Jan 2025	Common Stock	30,000	$0.000000	Direct	F1
transaction	EWTX	Stock Options (Right to buy)	Award	$0	+160,000		$0.000000	160,000	21 Jan 2025	Common Stock	160,000	$27.39	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Restricted Stock Units ("RSUs") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on January 21, 2026.
F2	1/4th of the shares subject to the option become vested and exercisable on January 21, 2026 and 1/48th of the shares subject to the option continue to vest each month thereafter, subject to the Reporting Person continuing as a service provider through each vest date.